REGULATORY
Japan Allocates 100 Billion-Plus Yen for Drug Innovation, Generic Funds: FY2025 Extra Budget
Japan has booked 152.7 billion yen in its FY2025 supplementary budget for measures to promote pharmaceutical innovation, reinforce stable drug supplies, and strengthen quality and safety oversight. The package includes 6.3 billion yen for direct support to drug wholesalers and…
To read the full story
Related Article
- Japan Finalizes Economic Package Positioning Pharma as “Core Industry”
November 25, 2025
REGULATORY
- MFN Now a Factor in Japan’s Drug Pricing Debate: New Pharma Policy Chief
September 11, 2026
- MHLW to Weigh Survey Data, Past Approach for FY2027 Revision: Official
September 10, 2026
- Chuikyo Reps Back Greater Transparency, but Lean toward Broader CEA Price Cuts
September 10, 2026
- OTC-Like Drug Charge Gets Prescription Field; No Double Charge with LLP Rule
September 10, 2026
- Defense Chief Seeks MHLW Help Securing Drugs for SDF
September 9, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





